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Abstract: Photobacterium damselae subsp. piscicida (Phdp) is a Gram-negative pathogen 
agent of an important fish septicemia. The key virulence factor of Phdp is the plasmid-
encoded exotoxin AIP56, which is secreted by exponentially growing pathogenic strains. 
AIP56 has 520 amino acids including an N-terminal cleavable signal peptide of 23 amino 
acid residues, two cysteine residues and a zinc-binding region signature HEXXH that is 
typical  of  most  zinc  metallopeptidases.  AIP56  induces  in  vitro  and  in  vivo  selective 
apoptosis of fish macrophages and neutrophils through a caspase-3 dependent mechanism 
that  also  involves  caspase-8  and  -9.  In  vivo,  the  AIP56-induced  phagocyte  apoptosis 
progresses to secondary necrosis with release of cytotoxic phagocyte molecules including 
neutrophil elastase. Fish injected with recombinant AIP56 die with a pathology similar to 
that seen in the natural infection. 
Keywords:  Photobacterium  damselae  subsp.  piscicida;  AIP56;  AB  toxin;  apoptosis; 
secondary necrosis 
 
1. The Apoptogenic Exotoxin AIP56 Is the Key Virulence Factor of Photobacterium damselae 
subsp. piscicida  
Photobacterium damselae subsp. piscicida (Phdp) is a Gram-negative pathogen that was isolated 
for  the  first  time  from  a  massive  fish  kill  in  Chesapeake  Bay  [1].  The  disease  has  been  named 
pseudotuberculosis and, after the initial classification of this agent as Pasteurella piscicida [2], as 
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pasteurellosis. The pathogen was later reassigned to the genus  Photobacterium as Photobacterium 
damsela  subsp.  piscicida  [3],  the  name  afterwards  corrected  to  Photobacterium  damselae  subsp. 
piscicida  [4].  Consequently,  the  disease  is  also  referred  to  as  photobacteriosis.  Phdp  is  highly 
pathogenic for wild and cultured marine fish and has been found to affect more than 20 warm water 
fish species worldwide, including sea bass, sole, yellowtail, gilt-head sea bream and turbot [5–7]. Phdp 
infection is now recognized as one of the most threatening bacterial diseases in mariculture worldwide 
due  to  its  wide  host  range,  massive  mortality,  ubiquitous  geographical  distribution,  widespread 
antibiotic resistance and lack of efficient vaccines [8]. In its acute form, this disease has a septicemic 
nature and has a short course and very high mortality [5,7,9]. 
Early descriptions of the histopathology of Phdp infection and of the toxicity of Phdp extracellular 
products  recognized  the  occurrence  of  cytotoxic  alterations  [6,10–16],  but  the  cytological 
characterization of these alterations and the mechanism for their production were not elucidated. The 
re-evaluation of the interaction of virulent Phdp with fish phagocytes was undertaken in our laboratory 
using the intraperitoneal (i.p.) inoculation in sea bass. This analysis revealed that the cytopathology 
previously  described  in  Phdp  infection  is  due  to  pathogen-induced  macrophage  and  neutrophil 
apoptotic death [17]. The virulence of Phdp strains from different geographical locations, including 
Portugal, Spain, Italy, Greece and Japan, was associated to the apoptogenic activity of the pathogen [17].  
Different studies have identified several factors/mechanisms that could be involved in the virulence 
of Phdp [6,11,18]. However, the recognition that (i) systemic macrophage and neutrophil apoptosis 
was a marked feature of experimental Phdp infections; (ii) apoptosis of macrophages and neutrophils 
was observed after injection of virulent bacterial culture supernatants but not of UV-killed virulent 
bacteria; and (iii) the apoptogenic activity of culture supernatants was abolished by heat-treatment, led 
us to admit that one (or several) protein(s) secreted by virulent Phdp strains would be responsible for 
the apoptogenic activity of these bacteria [17]. 
Considering that infecting Phdp in the host would be metabolically active, we searched for the 
putative apoptogenic factor in supernatants of mid-exponential cultures of Phdp [19]. Surprisingly, this 
search revealed a major protein band in the electrophoretic profiles of those supernatants of virulent 
Phdp but not in nonvirulent strains. This finding was in contrast to previous studies suggesting the 
secretion  of  a  highly  complex  mixture  of  different  proteins  by  Phdp  [20].  The  larger  protein 
complexity of the culture supernatants observed by those researchers could be explained by the fact 
that stationary-phase cultures were used in their studies.  
Concentrated cell-free culture supernatants from a virulent Phdp strain were resolved by native-
PAGE, fractionated, and the fraction containing the major protein showed in vivo capacity to induce 
apoptosis of sea bass macrophages and neutrophils, pointing to the likelihood of it being the virulent 
apoptogenic factor of pathogenic Phdp. SDS-PAGE analysis of that fraction revealed a single protein 
band  of  approximately  56  kDa.  The  protein  was  named  AIP56  (apoptosis  inducing  protein  of  
56 kDa) [19]. 
Recombinant  AIP56  expressed  in  Escherichia  coli  BL21  was  found  to  retain  the  apoptogenic 
activity of Phdp AIP56 towards macrophages and neutrophils when injected i.p. in sea bass or when 
the toxin was incubated ex vivo with peritoneal sea bass phagocytes. These results demonstrated that 
the exotoxin AIP56 is the factor responsible for the apoptogenic activity of virulent Phdp [19]. Toxins 2010, 2                          
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The primary structure of AIP56 has been characterized [19]. AIP56 was annotated as a 513 amino 
acid precursor protein, including an N-terminal cleavable signal peptide of 16 amino acid residues 
(GeneBank  Accession  number  DQ066884).  However,  an  alternative  GTG  start  codon  exists  21 
nucleotides ahead of the previously annotated ATG start codon, extending the signal peptide to 23 
amino acids and the full length protein to 520 amino acids. Moreover, AIP56 displays a hydropathic 
profile typical of a non-membrane protein.  
Table 1. Sequences producing significant alignments from Blast analysis of the AIP56 
protein  sequence  against  the  non-redundant  protein  database  at 
http://blast.ncbi.nlm.nih.gov/Blast.cgi. 
Accession  Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
YP_003422532.1  Aip56 [Photobacterium damselae subsp. piscicida]   1064  1064  98%  0.0 
BAF99004.1  apoptosis inducing protein [Photobacterium damselae subsp. piscicida]  1046  1046  98%  0.0 
ZP_02194626.1  hypothetical protein 1103602000593_AND4_00648 [Vibrio sp. AND4]   597  597  99%  9e-169 
CBA72068.1  non-LEE encoded type III effector C [Arsenophonus nasoniae]  306  306  94%  3e-81 
CBA72300.1  apoptosis inducing protein [Arsenophonus nasoniae]  281  281  93%  1e-73 
CBA76058.1  non-LEE encoded type III effector C [Arsenophonus nasoniae]  275  275  93%  7e-72 
YP_002308522.1  hypothetical protein D [Bacteriophage APSE-2]   194  194  36%  2e-47 
CBA74519.1  non-LEE encoded type III effector C [Arsenophonus nasoniae]  192  192  94%  8e-47 
ZP_04620510.1  Non-LEE encoded type III effector C [Yersinia aldovae ATCC 35236]   178  178  48%  2e-42 
NP_286533.1  hypothetical protein Z0986 [Escherichia coli O157:H7 EDL933]   178  178  50%  2e-42 
YP_003229213.1  T3SS secreted effector NleC-like protein [Escherichia coli O26:H11 str. 11368]   178  178  50%  2e-42 
YP_002328603.1  T3SS secreted effector NleC homolog [Escherichia coli O127:H6 str. E2348/69]   178  178  50%  2e-42 
YP_003234807.1  T3SS secreted effector NleC-like protein [Escherichia coli O111:H- str. 11128]  177  177  50%  4e-42 
YP_003234967.1  T3SS secreted effector NleC-like protein [Escherichia coli O111:H- str. 11128]   174  174  50%  2e-41 
YP_003365223.1  T3SS effector protein NleC [Citrobacter rodentium ICC168]   173  173  48%  6e-41 
ZP_03043710.1  non-LEE encoded type III effector C [Escherichia coli E22]   172  172  50%  7e-41 
ZP_02576318.1 
non-LEE encoded type III effector C [Salmonella enterica subsp. enterica serovar 
4,[5],12:i:- str. CVM23701]  
169  169  48%  9e-40 
YP_001762636.1  hypothetical protein Swoo_4286 [Shewanella woodyi ATCC 51908]   83.2  83.2  28%  6e-14 
ZP_03318593.1 
hypothetical protein PROVALCAL_01527 [Providencia alcalifaciens DSM 
30120]  
38.9  38.9  25%  1.7 
Two  other relevant aspects of AIP56 primary structure are the presence of only two cysteine 
residues (C
278 and C
314) and of a zinc-binding region signature HEXXH that is typical of most zinc 
metallopeptidases. Further characterization, using Blast analysis on non-redundant protein sequences 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi), revealed as the closest hit a homologous hypothetical 
protein of Vibrio campbellii, another widely distributed pathogen of cultured marine organisms [21] 
(Table  1).  The  next  hits  with  the  full  length  AIP56  were  four  recently  annotated  proteins  of 
Arsenophonus nasoniae, a son-killer bacterium of the wasp Nasonia vitripennis, resulting from four Toxins 2010, 2                          
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open  reading  frames  dispersed  throughout  the  genome  [22]  (Table  1).  These  AIP56-like  proteins 
present a primary structure highly similar to that of AIP56 (Figure 1). The Blast analysis also revealed 
the similarity of the N-terminal of AIP56 (first 324 amino-acids) with type III secreted effectors C 
from enteric pathogenic bacteria, and of the C-terminal with a hypothetical protein of the temperate 
lambda-like bacteriophage APSE-2, a phage that infects Hamiltonella defense, the endosymbiont of 
the pea aphid Acyrthosiphon pisum (reviewed in ref. [23]). Most remarkable is the conservation of the 
zinc-metalloprotease  signature  in  the  referred  type  III  secreted  effectors  (Figure  1).  The  above 
mentioned analysis suggests that AIP56 has two domains, possibly linked by a disulfide bridge. This 
hypothesis has been supported in our laboratory by limited proteolysis experiments, which showed the 
existence of two major digestion fragments with sizes consistent with the two putative AIP56 domains 
predicted by homology analysis (unpublished results). N-terminal sequencing and MS analysis of the 
chymotrypsin digestion fragments revealed that the cleavage occurs between F
285 and F
286 lying in the 
amino-acid  stretch  between  the  two  unique  cysteine  residues  (C
278  and  C
314),  and  analysis  of  the 
digests under non-reducing conditions confirmed the existence of a disulfide bridge linking the two 
proteolytic fragments, as a single band of 56 kDa was obtained.  
The above data led us to hypothesize that AIP56 is an AB-toxin, similar to tetanus and botulinum 
neurotoxins. Tetanus and botulinum neurotoxins are AB toxins that possess an A domain displaying 
metalloprotease activity linked to a B domain by a single disulfide bridge [24,25]. Considering that the 
AIP56 N-terminal region has a high identity with type III effectors from enteric pathogenic bacteria, 
and that a zinc-metalloprotease signature is conserved both in the AIP56 N-terminal and in the type III 
effectors, we hypothesize that the N-terminal region is responsible for the toxin‟s apoptogenic activity 
and the C-terminal region would be responsible for the toxin binding/entry into the cells. Further 
studies are presently ongoing to assess this hypothesis. 
As observed for many bacterial toxin-specific genes, which are often located on mobile genetic 
elements [28], AIP56 was also found to be encoded in a high-copy plasmid present in all virulent Phdp 
strains  tested  and  from  diverse  geographical  locations  [19].  The  location  of  the  AIP56  gene  in  a  
high-copy plasmid is probably the reason why Phdp virulent strains are capable of producing large 
amounts of exotoxin. 
Like  in  other  pathogens,  the  virulence  of  Phdp  certainly  is  multifactorial.  However,  the  
AIP56-dependent  pathogenicity  mechanism  most  likely  is  central  in  the  etiopathogenesis  of  fish 
pasteurellosis because: (i) the AIP56 gene is present in all virulent strains and absent in the non-
virulent  isolates  tested  [19];  (ii)  systemic  phagocyte  destruction  similar  to  that  seen  in  fish  with 
advanced natural or experimental pasteurellosis was seen in moribund fish following the inoculation of 
recombinant AIP56 [29]; (iii) passive immunization with anti-AIP56 rabbit serum protects sea bass against 
Phdp infection [19]. 
The importance of this novel pathogenicity factor of Phdp is emphasized by the observation that 
AIP56-induced apoptotic phagocyte destruction observed in experimental infections also occurs in sea 
bass and sole with natural Phdp infection [29]. Toxins 2010, 2                          
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Figure  1.  Schematic  diagram  comparing  the main  features  of  the  primary  structure  of 
AIP56 with proteins retrieved by Blast analysis of the AIP56 protein sequence against the 
non-redundant protein sequences database. Striped bars represent signal peptides according 
to  SignalP  at  http://www.cbs.dtu.dk/services/SignalP/  [26,27].  The  conserved  zinc-
metalloprotease signature HEXXH and cysteine residues are represented at their relative 
positions. Numbers represent amino acid residues. 
 
2. AIP56 Induces a Typical Apoptotic Death in Fish Macrophages and Neutrophils 
The initial observations in sea bass experimental Phdp infection pointed to the selective targeting of 
both  professional  phagocytes  by  a  Phdp  cytotoxin  [17].  To  better  dissect  the  anti-phagocyte 
apoptogenic activity of AIP56, an ex vivo model was used. The cells used in the ex vivo studies were 
inflammatory  peritoneal  leukocytes  collected  from  peritoneal  cavities  of  sea  bass  injected  with 
Incomplete Freund‟s Adjuvant 15 days before collection [19] (Figure 2). The apoptotic nature of the 
alterations seen in these leukocytes was established by the presence of a set of indicators [30–32]: cell 
shrinkage,  chromatin  condensation,  nuclear  fragmentation,  production  of  apoptotic  bodies, 
internucleosomal  DNA  degradation  revealed  by  nuclear  TUNEL  positivity  and  by  DNA 
electrophoresis, and activation of the apoptosis executioner caspase-3. These experiments showed that 
the only cells in the inflamed peritoneal population affected by the apoptogenic activity of AIP56 were 
macrophages and neutrophils [19]. The apoptogenic activity of AIP56 against the murine macrophage 
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cell line J774, bone-marrow derived mouse macrophages and Drosophila S2 macrophage-like cell line 
was also tested. AIP56 did not display apoptogenic activity against those cells (unpublished results).  
Recent results [33,34] showed that the AIP56-induced selective apoptosis of fish macrophages and 
neutrophils  also  involves  activation  of  caspases-8  and  -9.  Following  the  molecular  cloning  and 
characterization of sea bass caspases-3, -8, and -9, the expression of these caspases was analyzed in sea 
bass with experimental Phdp infection or injected with AIP56-containing Phdp culture supernatants. 
The very low basal expression of those caspases increased in the initial 12–24 h post-infection or  
post-injection. Additionally, caspase-3, -9, and -8 proteolytic activities were detected in organs of sea 
bass with terminal infection [29,33,34].  
Involvement  of  mitochondria  was  also  found,  as  shown  by  loss  of  mitochondrial  membrane 
potential, translocation of cytochrome c to the cytosol and over-production of ROS. 
Figure 2. Wright-stained cytospins of sea bass peritoneal leukocytes 4 h after i.p. injection 
of  2  μg  of  recombinant  AIP56  (AIP56H+)  or  the  same  amount  of  heat-inactivated 
recombinant AIP56 (control). Neutrophils were labeled by peroxidase detection (brown 
granules).  In  cells  exposed  to  AIP56H+,  note  the  occurrence  of  extensive  nuclear 
fragmentation and chromatin condensation in macrophages (M) and neutrophils (N), cell 
blebbing  in  neutrophils,  and  the  presence  of  apoptotic  bodies  (AB).  The  eosinophilic 
granular cells (E) look normal in both samples. Objective 100 × . From reference [19]. 
 
3. Pathogenetic Consequences of the in Vivo Cytopathological Effects of AIP56 Toxin 
Apoptosis  [35]  is  one  mode  of  active  cell  death  that,  in  multicellular  animals,  is  a  major 
physiological cell killing process used during embryonic morphogenesis and in adult life in tissue 
homeostasis and immune responses for the elimination of unnecessary, unwanted or dangerous cells 
[36,37].  Typically,  in  physiological  situations,  the  apoptotic  mode  of  cell  elimination  is  a  useful 
process since it is induced when appropriate, comprises the induction of a safe mechanism for cell 
disposal through the removal of apoptosing cells by scavenger cells, and, although spending energy, is Toxins 2010, 2                          
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economical in terms of re-utilization of the products of this disposal [35]. However, the perspective of 
apoptosis  as  a  useful  process  is  restrictive,  since  this  mode  of  cell  elimination  can  be  subverted, 
leading to harmful pathological situations. In this context, it has to be noted that fully developed 
apoptosis leads to necrotic cell disintegration. Indeed, soon after the proposal the term apoptosis [35], 
it was recognized that in vitro apoptosis proceeds to necrosis leading to cell disruption [38,39], a 
process called secondary necrosis [30]. However, in multicellular organisms, the apoptotic process 
comprises a mechanism for the removal and degradation of the apoptosing cell through phagocytosis 
by scavenger cells, mainly macrophages [40,41]. This removal occurs while the apoptosing cell still is 
enveloped by a membrane that retains potentially harmful components, thus preventing the progression 
to  secondary  necrosis.  When  insufficient  removal  of  apoptosing  cells  occurs,  secondary  necrosis 
ensues leading to cell lysis, which is pathogenetic [42]. Insufficient clearance of apoptosing cells in 
vivo has been described in situations of massive apoptosis that overwhelms the available scavenging 
capacity  [43–45],  or  when  this  capacity  is  directly  impaired  by  deleterious  effects  on  
macrophages [46–49].  
Apoptosis also turns pathological when the killed cells are necessary and functional, for example in 
degenerative disorders and in infectious diseases when pathogens destroy protective immune cells 
leading to evasion from host anti-microbial mechanisms [50–53]. 
In the early phase of infection, Phdp is seen within macrophages in natural [9] and experimental 
Phdp infection [13,29]. However, as the infection progresses, systemic dissemination of the pathogen 
occurs as indicated by the isolation of increasing numbers of bacteria from the blood and organs in fish 
experimentally  infected  with  Phdp  [29].  Systemic  dissemination  is  accompanied  by  extensive 
extracellular  bacterial  multiplication  as  suggested  by  the  observation  of  dense  aggregates  of 
extracellular bacteria (micro-colonies) in infected tissues. Extracellular Phdp are present in the spleen, 
headkidney,  liver,  gut  lamina  propria  and  blood,  indicating  that  advanced  Phdp  infection  is  a 
septicemic situation. The septicemic spread of Phdp in the infected host is paralleled by the occurrence 
of AIP56 in the plasma [29]. 
Extensive infiltration of macrophages and neutrophils occurs in the initial phase of infection when 
local multiplication of Phdp becomes detectable in infected tissues [29]. This initial accumulation of 
phagocytes is followed by extensive phagocyte depletion in advanced experimental Phdp infections 
[29]. This depletion correlates with the appearance of high numbers of macrophages and neutrophils 
with apoptotic features  [17,29]. Apoptosing cells, identified by an apoptotic morphotype, TUNEL 
positivity and presence of active caspase-3, were seen in foci and scattered in the splenic and head 
kidney parenchymas, in the peripheral blood, in blood of the spleen, liver and head kidney vasculature 
and in gut lamina propria. In fish experimentally infected with Phdp or injected with the toxin AIP56, 
detachment  of  enterocytes  was  observed  [54];  the  detached  enterocytes  enter  detachment-induced 
epithelial cell apoptosis or anoikis [55]. Supporting the interpretation that AIP56 is the apoptogenic 
factor of Phdp towards fish macrophages and neutrophils, leukocytes with apoptotic features present in 
Phdp-infected tissues immunostain for AIP56 [29] (Figure 3). Toxins 2010, 2                          
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Figure  3.  Blood  in  a  vessel  of  the  spleen  of  a  sea  bass  with  advanced  natural  Phdp 
infection  labeled  by  immunocytochemistry  for  AIP56  exotoxin.  Apoptosing  cells  with 
fragmented  nuclei  and/or  condensed  chromatin  are  immunostained  for  AIP56  (brown). 
Objective 100 × . From ref. [29]. 
 
In advanced Phdp infection, foci of necrosis with abundant cell debris are prominent [29]. There are 
data that support the interpretation that this necrosis is the result of the progression of phagocyte 
apoptosis  to  secondary  necrosis  due  to  the  lack  of  removal  of  abundant  apoptosing  phagocytes. 
Activated caspases are released by cells undergoing apoptotic secondary necrosis when rupture of the 
cytoplasmic membrane occurs [56] and occurrence of relevant apoptotic secondary necrosis can be 
detected in vivo by the presence of increased levels of extracellular activated caspases, which can be 
quantified in the blood [57–59]. An indication that the extensive phagocyte lysis in the advanced phase 
of the disease is due to the progression to secondary necrosis of the phagocytes is the observation in 
terminal infection of elevated blood levels of activated caspase-3 [29]. This result agrees with the 
observation  by  electron  microscopy  in  fish  with  advanced  Phdp  infections  of  phagocytes  with 
condensed  chromatin  and  fragmented  nuclei  (typical  of  apoptosing  cells)  together  with  ruptured 
cytoplasmic membrane (typical of necrosis) [17], a hallmark of secondary necrosis [42]. 
Lysis of phagocytes by secondary necrosis, leading to the release of highly cytotoxic components, 
is particularly pathogenetic in the case of neutrophils. Neutrophils are extraordinarily rich in highly 
cytotoxic components which, if released in excess, can damage many types of cells, with the potential 
to produce tissue injury [60–62]. One such molecule is the destructive enzyme neutrophil elastase 
[62,63]. Active neutrophil elastase was found in the plasma of fish with terminal Phdp infection [29]. 
In fish with advanced disease the levels of circulating active neutrophil elastase highly correlated with 
the levels of circulating activated caspase-3, suggesting that in terminal Phdp infection neutrophil lysis 
was due to secondary necrosis. 
Experimental [17,29] and natural [5,7] acute Phdp infections are rapid, severe infections with a very 
high mortality. This may be related to the characteristics of the AIP56-dependent Phdp pathogenicity 
mechanism  that  indicate  that  it  is  a  highly  potent  one,  as  follows.  First,  using  an  exotoxin,  this 
mechanism can operate at a distance without requiring contact between the pathogen and the target Toxins 2010, 2                          
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cells. Second, apoptotic destruction of both macrophages and neutrophils, AIP56 not only impairs the 
participation of these leukocytes in phagocytosis and killing of Phdp, but also releases intraphagocytic 
bacteria present in the initial phase of the infection, two effects that promote survival of the pathogen 
and its unrestricted extracellular multiplication. Concomitantly, the AIP56-induced apoptosis of both 
professional phagocytes leads to tissue damage with deleterious consequence for the host. In fact, 
destruction of macrophages, the cells with the crucial role of eliminating apoptotic cells [40,41], results 
in deficient clearance of AIP56-induced abundant apoptotic neutrophils, which leads to their lysis by 
secondary necrosis [17], with the severe consequences due to the release of highly cytotoxic neutrophil 
molecules  [60–62].  Finally,  relying  on  a  potent  protein  exotoxin,  this  pathogenicity  mechanism 
requires the production of anti-AIP56 antibodies as a defensive response from the host, an adaptive 
immune response that cannot be achieved in the short time lapse of this fulminant infectious disease. 
In  innate  and  adaptive  anti-bacterial  immune  responses  macrophages  and  neutrophils  work  in 
concert as crucial elements of host defense against infection as the effectors of the myeloid phagocyte 
system [64,65]. The ability of bacterial pathogens to cause timely phagocyte cell death is important for 
virulence [66], and this anti-phagocytic mechanism may follow phagocytosis of the pathogen, depend 
on direct contact between the pathogen and the host cell target with transfer of effector molecules by 
secretion systems [67,68], or be mediated by exotoxins as in the case of Phdp. The simultaneous 
targeting of macrophages and neutrophils by Phdp through the AIP56 exotoxin thus represents a very 
effective pathogenicity strategy which contributes to the severity of acute Phdp infections. This ability 
of pathogens to simultaneously target the two professional phagocytes in vivo is not common, but a 
few examples have been reported, as is the case of Pseudomonas aeruginosa [69,70], Yersinia pestis 
[71] and Francisella tularensis [72,73]. 
In  conclusion,  the  identification,  characterization  and  production  of  recombinant  active  AIP56 
allowed the clarification of the key virulence factor of an important fish pathogen and revealed a 
relevant  bacterial  pathogenicity  weapon  relying  on  a  largely  underestimated  anti-phagocyte 
mechanism based on the lysis by apoptotic secondary necrosis of macrophages and neutrophils by a 
bacterial cytotoxin. The observation that neutralization of AIP56 activity by transfer of anti-AIP56 
antibodies  is  effective  in  protecting  sea  bass  against  experimental  Phdp  infection  open  promising 
prospects towards the development of an effective anti-Phdp vaccine based on AIP56. Finally, the 
observed homology between AIP56 and type III secreted effectors from enteric pathogenic bacteria 
suggests  possible  commonalities  between  pathogenicity  mechanisms  of  Phdp  and  those 
enteropathogens, with implications for human infections.  
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